Superworth

Biotech stocks with the highest profit margins

Net income over the last twelve months as a share of revenue. As of .

Ranked
29
of 146 biotech stocks we cover
Median
10.7%
Highest
69.3%
AGEN
Range
−89.1% to 69.3%
median 10.7%
−89.1%69.3%
#CompanyNet marginOperating marginRevenue growth (TTM)Market cap
1AGENAgenus69.3%27.3%+30.5%$285M
2KRYSKrystal Biotech54.8%44.9%+22.6%$9.2B
3UTHRUnited Therapeutics41.6%44.4%+2.5%$25.2B
4EXELExelixis35.3%39.9%+9.2%$16B
5VRTXVertex Pharmaceuticals35.0%38.0%+10.2%$132.8B
6ADMAAdma Biologics33.0%43.8%+8.0%$2.4B
7REGNRegeneron Pharmaceuticals27.9%24.7%+9.3%$82.9B
8INCYIncyte27.7%30.6%+26.9%$23.5B
9HALOHalozyme Therapeutics24.9%35.9%+41.2%$14.3B
10PLXProtalix BioTherapeutics23.5%28.9%+30.1%$205.5M
11NBIXNeurocrine Biosciences20.9%23.6%+34.4%$14.5B
12MGTXMeiraGTx19.9%46.3%n/m$884.6M
13ALNYAlnylam Pharmaceuticals16.8%20.8%+95.1%$30B
14TECHBIO-TECHNE15.0%20.7%−0.4%$11.4B
15ONCBeOne Medicines10.7%15.1%+34.3%$42.9B
16VCELVericel7.9%6.0%+23.0%$2.2B
17RGENRepligen5.3%8.2%+16.5%$10B
18CSBRChampions Oncology−1.8%−1.7%+6.7%$65.7M
19IMCRImmunocore−4.2%−5.2%+21.0%$1.6B
20FENCFennec Pharmaceuticals−5.5%−1.9%+77.8%$353.5M
21TARSTarsus Pharmaceuticals−7.7%−8.0%+105.2%$3B
22ADPTAdaptive Biotechnologies−20.7%−12.2%+50.1%$4.1B
23TWSTTwist Bioscience−31.7%−33.6%+19.2%$8.8B
24BCRXBiocryst Pharmaceuticals−40.9%−33.3%+68.7%$2B
25BEAMBeam Therapeutics−54.7%n/m+158.9%$2.5B
26NVAXNovavax−59.9%−56.6%−61.6%$1.6B
27INSMInsmed−76.9%−73.9%+185.8%$20.4B
28VIRVir Biotechnology−83.0%−92.4%n/m$1.8B
29IOVAIovance Biotherapeutics−89.1%−92.7%+34.5%$6.4B

Not ranked: 44 with a margin moved by items that are not sales, 29 with not a meaningful number, 16 with a quarter missing, 3 with no margin to measure. 25 companies whose data behind this number has a caveat are left out until it is checked.

A ranking of numbers, not a recommendation. A low multiple can be a bargain or a business in trouble: open the company to see which.

Net margin for other groups

Other rankings of biotech stocks

The group